Mechanism-guided design improves precision photodynamic therapy by reducing nonspecific effects in oncology.
The clinical application of conventional photodynamic therapy (PDT) is often limited by the nonspecific phototoxicity of "always-on" photosensitizers. Activatable photosensitizers (aPS) have emerged as a promising solution to this challenge....
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: